Recruiting

Observational Study

Sponsor:

University of Cincinnati

Code:

NCT04342403

Conditions

Sarcoidosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Quality of Life

Study Details

Brief summary:

Evaluate change of quality of life of sarcoiodosis patients over a six months using various quality of life instruments including a monthly smart phone app.

Conditions

Sarcoidosis

Study ID

NCT04342403

Start date

Apr 1, 2017

Status verified date

Apr, 2020

Completion date

Dec 1, 2020

Anticipated

Primary completion date

Dec 1, 2020

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of sarcoidosis by established criteria.
  • Patient has completed pulmonary function tests (spirometry) as per standard of care at the enrollment visit.
  • Ability to understand and read English at least at a 7th grade level.
  • Have access to a computer, iPad, smart phone, or another electronic device that will support the on-line sarcoidosis assessment platform.
  • The subject is willing to wear a daily activity and sleep tracker wristband (Fitbit ™ wristband) for 6 months.

Exclusion Criteria:

• Life expectancy of < 1 year.

Study Design

Enrollment

350 participants

Anticipated

Interventions and Outcome Measures

Arms

Sarcoidosis

Patients with sarcoidosis willing to participate

Interventions

Quality of Life

Quality of life instruments including King's Sarcoidosis Questionnaire (KSQ) and Sarcoidosis Assessment Tool (SAT)

Primary outcome measure

  • KSQ [ Time Frame: 6 months ]

Central Contacts and Locations

Locations

Albany Medical Center

Recruiting

Albany, New York, United States, 12208

Contacts

Marc Judson, MD

518-262-5196JudsonM@amc.edu

University of Cincinnati

Recruiting

Cincinnati, Ohio, United States, 45267

Contacts

Robert P Baughman, MD

513-584-5225bob.baughman@uc.edu

Elyse E Lower

513-584-3829ELower@ucmail.uc.edu

Cleveland Clinic

Recruiting

Cleveland, Ohio, United States, 44195

Contacts

Dan Culver

216-444-2200CULVERD@ccf.org

Principal Investigator:

Dan Culver

More Information

Sponsor

University of Cincinnati

Last update posted

Apr 13, 2020

Last verified

Apr, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-11. This information was provided to ClinicalTrials.gov by University of Cincinnati on 2020-04-13. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.